Utility of unilateral versus bilateral venous reflux studies for venous insufficiency.


Journal

Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771

Informations de publication

Date de publication:
09 2021
Historique:
received: 05 08 2020
accepted: 14 01 2021
pubmed: 3 2 2021
medline: 27 1 2022
entrez: 2 2 2021
Statut: ppublish

Résumé

Duplex ultrasonography is the reference standard for diagnosing chronic venous insufficiency. Bilateral venous reflux ultrasound studies are among the most time-consuming and physically demanding tests for vascular ultrasound technologists to perform. Furthermore, if a venous procedure is required, many insurance policies require that a diagnostic venous ultrasound scan for reflux must be performed within 1 year of the procedure. If the intervention is scheduled for >1 year after the ultrasound scan, the insurance company might require a repeat venous ultrasound scan before granting insurance authorization. Hence, ordering bilateral venous duplex ultrasound scans to evaluate for reflux when an intervention might only be performed on one limb within the year could be a waste of time and resources. The aim of the present study was to determine the utility of ordering bilateral vs unilateral studies to evaluate for reflux in patients with suspected chronic venous insufficiency and to determine whether a resource-saving potential exists for vascular laboratories through optimization of the process of ordering venous duplex ultrasound studies. A retrospective review of all patients who had undergone bilateral lower extremity ultrasound scanning to evaluate for reflux from January 1, 2016 to December 31, 2016 at the Massachusetts General Hospital vascular laboratory was performed. The demographics, indications for ultrasound scanning, comorbidities, time required to perform the ultrasound study, and interval to intervention were documented. The data were analyzed using SPSS statistical software (IBM Corp, Armonk, NY). During the study period, 13,854 ultrasound studies had been performed in our vascular laboratory, of which 606 (4.4%) had been bilateral ultrasound scans for venous insufficiency. The time allotted for a bilateral study was 2 hours. Of the 606 studies evaluated, 152 (25.1%) showed no evidence of reflux, 284 (46.9%) showed bilateral lower extremity reflux, and 170 (28.1%) showed only venous insufficiency in one leg. Venous ablation, phlebectomy, and/or sclerotherapy were performed for 28.7% of the patients. However only 6.2% of patients had undergone venous procedures on both legs within 1 year after the ultrasound studies. Ablation was the most common procedure performed (54.6%), followed by phlebectomy (27.%) and sclerotherapy (17.9%). Overall, 94.7% of patients had not undergone a venous procedure on both legs within 1 year after the ultrasound studies and, hence, would have required a repeat duplex ultrasound scan to ensure insurance coverage for future procedures. Most bilateral ultrasound scans for venous insufficiency will not result in an intervention. Thus, most patients (95%) could have undergone a unilateral scan before the initial intervention instead of bilateral duplex ultrasound scanning.

Identifiants

pubmed: 33529718
pii: S2213-333X(21)00063-9
doi: 10.1016/j.jvsv.2021.01.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1297-1301

Informations de copyright

Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Brandon J Sumpio (BJ)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass. Electronic address: Brandon.Sumpio@mgh.harvard.edu.

C Y Maximilian Png (CYM)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Anita Harrington (A)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Drena Root (D)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Robert McLaughlin (R)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Scott Manchester (S)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Christopher A Latz (CA)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Zachary M Feldman (ZM)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Matthew Eagleton (M)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Anahita Dua (A)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH